A clinical evaluation of dose and schedule of administration of cytosine arabinoside (NSC 63878).
D001774:Blood Chemical Analysis; D001853:Bone Marrow / Q000187:drug effects; D001854:Bone Marrow Cells; D002986:Clinical Trials as Topic; D003561:Cytarabine / Q000008:administration & dosage* / Q000627:therapeutic use* / Q000633:toxicity; D006801:Humans; D007263:Infusions, Parenteral; D007275:Injections, Intravenous; D007958:Leukocyte Count; D009369:Neoplasms / Q000188:drug therapy*
D003561:Cytarabine